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In this review we question the current way of handling tackle a problem of chronic cough, especially by the
excessive number of patients who can not find complete relief from your cough by anatomical diagnosis of
universal use. From the field of Otolaryngology new perspectives arise now considering the larynx as a preferential
afferent stimuli cough reflex arc. Also the constitution laryngopharyngeal reflux gas and new approaches to
non-acid reflux and the local action of pepsin in laryngeal deserving of a joint review, which can illuminate new
ways to handle the problem of chronic refractory cough. We believe that the chronic cough syndrome
hpersensitivity as more precise label for chronic cough, should place particular emphasis on laryngeal sensory
neuropathy as cough and reflux the influence that may have on their maintenance, and thereby causes definitely
wide related to the syndrome if the larynx is incorporated, place greater number of afferent nerves of chronic
cough, which are sure to cover much of the case of refractory cough remain without a satisfactory solution. The
close collaboration between Otolaryngology, Gastroenterology and Pneumology in a patient with refractory chronic
cough seems now an unavoidable necessity.Introduction
Cough is the final result of a vagally-mediated reflex and is
part of a vegetative vagal function including swallowing and
voice. Cough has a homeostatic function but it may also be-
come a source of problems. Chronic cough (CC) affects as
many as 10% of the general population [1]. The clinical
diagnosis of chronic cough is based on cause and effect in
conditions such as asthma, gastroesophageal reflux (GER)
and upper airway syndrome, but not in diseases such as
COPD, cancer, and heart failure which do not necessarily
imply cause and effect [2]. In cases of cause-effect CC, after
ruling out eosinophilic airway inflammation (asthmatic or
non-asthmatic eosinophilic bronchitis) there is growing evi-
dence that the most important etiology is a sensory dis-
order of the laryngeal branches of the vagus nerve. In these
cases laryngopharyngeal reflux (LPR) is often concurrently
diagnosed [3,4]. This is no surprise, since the vagus nerve
supplies the entire aerodigestive tract, including the upper* Correspondence: doctorpachecogalvan@gmail.com
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distribution, and reproduction in any mediumand lower respiratory tracts and the digestive tract. The
present review focuses on the relationship between sensory
vagal neuropathy and LPR and its impact on the treatment
of refractory CC.
Upper airway cough syndrome (UACS), an important
component of the diagnostic triad in CC, is of interest to
three medical specialties: otolaryngology (ENT), pneu-
mology and gastroenterology. Recently it has been the
focus of attention in research into the diagnosis and treat-
ment of refractory CC.
Unlike pulmonary CC patients, ENT patients with CC
almost always have associated symptoms such as globus,
dysphagia, dysphonia, dyspnea and/or stridor. However,
although the onset of CC is associated with eosinophilic
airway inflammation, it may also be associated with GER
[5]. A problem still being debated in the CC literature is
the fact that the condition may be the only (or the pre-
dominant) symptom of distinct pathologies located in dif-
ferent sites – for example, the upper airways, the lungs, or
the digestive area – each one of which may trigger the
cough reflex. Therefore, the temptation to describe a syn-
drome with a common denominator such as CC is veryCentral Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly cited.
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cough reflex was shown in relation to CC from many loca-
tions, all innervated by the vagus nerve, this finding led to
the definition of Chronic Cough Hypersensitivity Syn-
drome (CCHS). Thus, CC is no longer a symptom, but
has become a syndrome.
However, the prevalence of unexplained CC varies be-
tween clinics and in some studies has been reported to be
as high as 42% [6]. This has led to calls for a new approach
to chronic cough. For example, serious problems remain
regarding the conceptualization of UACS, since the cohort
of symptoms deriving from laryngeal neuropathy and /or
LPR can be confused with those of extraesophageal reflux
[7]. As a result, specific symptoms deriving from laryngeal
conditions such as laryngospasm or paradoxical vocal fold
motion (PVFM) are rarely considered in the CC guides
[8,9]. The theory that CC predominantly initiates in the la-
ryngeal area is gaining ground today, especially now that
the triad of eosinophilic airway inflammation, GER and
rhinitis-sinusitis has been ruled out. There is growing evi-
dence that the larynx, the bridge area between esophagus
and tracheo-bronchial tree, is one of the key sites of the af-
ferent limb of the cough reflex, and may be especially im-
portant in cases of refractory CC. Recent reports of
improvements in refractory cases of CC treated with
speech pathology intervention are of great interest [10,11].
Diagnosis and treatment protocols for CC are usually pro-
duced by pneumologists [8,9]; however, ENT specialists
have recently announced new perspectives in management
and treatment [3], supporting the idea that a laryngeal
neuropathy is responsible for many of the previously re-
fractory cases of chronic cough. As the focus in studies of
CC turns towards the larynx [3,12,13], pulmonologists are
gradually losing their predominant position; or, more
exactly, it is becoming more evident that CC requires
close cooperation between these two specialties, and that
gastroenterologists should also be involved in the develop-
ment of protocols for treating the condition.
Developments in the cough reflex arc
The afferent limb of the vagus nerve innervates diffuse
structures of the aerodigestive tract and is responsible for
the development of the cough reflex. These structures in-
clude the ear, pharyngeal branches, superior laryngeal
branches, pulmonary branches, gastric branches from the
stomach, cardial and esophageal branches and vagally in-
nervated viscera. One of the methodological problems in
basic research into CC is that the cough pathways in in-
flamed airways may be quite different from the ones ob-
served in healthy airways. Airway sensory afferent nerves
terminate in the brainstem at the level of the nucleus
tractus solitarius [14]. In animal models it has been dem-
onstrated that although general anesthesia may depress
the respiratory center, the cough reflex remains intact.There are at least five types of intraepithelial sensory re-
ceptors in the cough reflex. The most important are the
rapidly adapting stretch receptors (RARs) and the bron-
chial C fiber receptor. In general, the distribution of the
receptors is more mechanosensitive toward the larynx and
more chemosensitive in the distal airway [12]. Current
data support the hypothesis that at least two types of vagal
nerves are responsible for initiating the cough reflex arc.
One type is characterized by rapidly adapting responses to
mechanical probing or acidification of the large airway
epithelium. These nerves, which are capsaicin-insensitive,
are important in immediate cough evoked by aspiration,
and perform a critical role in airway defense. The other
primary afferent nerve involved in cough is the capsaicin-
sensitive vagal C-fiber. In clinical studies, inhalation of a
low concentration of a C-fiber stimulant causes an irritat-
ing, itchy urge-to-cough sensation associated with respira-
tory tract infection, gastroesophageal reflux disorders, and
inflammatory airway diseases [15]. Interestingly, acidifica-
tion is a trigger in both types of afferent nerve.
Also important is the finding that some C-fibers may be
linked to an inhibition of the cough reflex evoked by
inflammatory mediators. Two strategies are currently pro-
posed for the treatment of cough: decreasing the generator
potential amplitude by acting on TRPV1 and TRPA1, and
decreasing the efficiency with which a generator potential
evokes the action-potential discharge (the voltage-gated
sodium (NaV) channel), which is activated when the
depolarization is of sufficient magnitude for the channel
to open and the action potential discharge to be initia-
ted [16].
However, the overlapping responsiveness of the cap-
saicin-sensitive and -insensitive vagal afferent nerves regu-
lating cough argues against the validity of this distinction
[15,17]. Cough should be seen as a phenomenon with a
multifactorial origin; it should be accepted that the pres-
ence of a single origin is rare, and in fact the idea of differ-
ent simultaneous locations is gaining support. According
to Canning et al., it is apparent that multiple afferent nerve
subtypes act in concert to regulate the sensitivity, forceful-
ness, and repetition of cough in response to all tussive
stimuli. These authors hypothesize that alterations in
cough reflex sensitivity may be attributable to alterations
in the excitability of both afferent nerve subtypes and that,
as a result, therapies targeting either pathway may provide
benefit [18]. It is now accepted that a single stimulus – for
example bronchospasm, acid in the esophagus or upper
airway challenges with a variety of inflammatory media-
tors – is consistently ineffective in initiating cough in ani-
mals or human subjects and that the integration of the
stimuli of several afferent limbs of the vagus nerve is ne-
cessary. There is considerable evidence of convergent
vagal afferent nerve subpopulations relaying neurons in
the nucleus of the solitary tract. This convergence may
Pacheco and Cobeta Cough 2013, 9:10 Page 3 of 7
http://www.coughjournal.com/content/9/1/10account for the imprecision of the visceral reflexes; the ac-
tivation of a reflective body initiates changes in output
flow to other autonomous organs, as Mazzone et al. dem-
onstrated in guinea pigs [19]. This may also explain why
the initial signal of the cough reflex is weak, but may be
severe and chronic if reflex arc activation is recorded in
several sites, as for example in the conjunction of eosino-
philic airway inflammation and GER [5].
A good example of this concept is the role of reflux, as a
precipitant of the cough reflex arc at several levels: not only
the esophagus but upper respiratory and lower respiratory
tracts [20]. However, there are two problems with this the-
ory of a leading role for reflux: i) the question of whether
GER causes cough, or vice versa, and ii) the lack of consen-
sus on definitions in the extraesophageal area which may
be affected by reflux. The functional diagnosis of GERD is
verified in three ways: sustained distal acid esophageal ex-
posure (pHmetry), microaspiration due to ineffective super-
ior laryngeal sphincter (double pHmetry), or ineffective
esophageal motility and prolonged acid clearance [21].
However, the nature of the reflux is important to diagnosis.
In the case of CC from the upper airway, studies such as
Kavamura et al. can be revealing; those authors showed that
the gas with weak acidity reflux is more common among
patients with laryngeal lesions than in patients with GERD
or in controls [22]. Currently it seems of paramount im-
portance to reach a consensus on the nature of the reflux
(acid or non-acid, gas or liquid) and on the use of an upper
airway pH of 5 as pathological threshold. Therefore new
techniques like the Dx-pH measurement system (Dx-pH;
Restech Corporation, San Diego, CA) which can measure
the pH of pharyngeal gas reflux, and multichannel in-
traluminal impedance and pH testing (MII-pH) which can
detect non-acid liquid reflux, should be implemented in the
analysis of extraesophageal reflux [23].
One of the least explored associations of potential reflux
provoking CC, apart from the consideration of non-acid
reflux, is that of cough and esophageal dysmotility. This
combination does not always respond to antacid therapy
and is rarely analyzed in depth [24,25]. Moreover, it may
represent a generalized abnormality of the neural aero-
digestive network and, under a unified hypothesis, afferent
vagal branches from the bronchus or upper airway may
collaborate in the maintenance of CC. High-resolution
manometry is recommended by the American Gastro-
enterology Association Institute to evaluate patients with
suspected GERD syndrome who have not responded to
empirical twice-daily PPI therapy and have normal endo-
scopic findings [26].
CC as a laryngeal symptom
After ruling out the use of ACE inhibitors, smoking, COPD
or altered chest X-ray, heightened cough reflex sensitivity
is associated with eosinophilic airway inflammation, GERand UACS, the latter usually associated with rhinitis sinus-
itis in the CC guidelines [8,9]. In the larynx, cough reflex
and laryngeal closure reflex coexist and play an important
role both in protecting the airway during swallowing and
also in response to noxious inhaled stimuli. The sensory
nerve ending receptors which stimulate vocal cord closure
and cough as part of the glottic closure reflex are found
not only in the larynx but in the trachea and larger airways
as well, and these may respond to pressure or to irritant
stimuli. Hence, breathlessness is a relatively common find-
ing in the clinical history of patients with laryngeal pre-
dominant symptoms plus CC [27]. However, triggers that
stimulate the afferent limb of the cough reflex are now rec-
ognized to be an important part of the neurophysiology of
cough, and in recent years it has been demonstrated that
CC patients frequently report symptoms that suggest
sensitization of the cough reflex and a neuropathic re-
sponse. For example, after an acute episode of allergy, vi-
ruses, non-specific irritants or laryngopharyngeal reflux
(LPR) a laryngeal sensory defect may develop and CC may
remain as the most relevant symptom, though rarely the
only one [3,11].
The three terms most frequently used in the literature
and in clinical practice to refer to CC of predominantly
laryngeal origin are paradoxical vocal fold movement
(PVFM), laryngospasm, and vocal cord dysfunction (VCD).
All these entities have a common basis, the permanent or
intermittent closure of the glottic area. Many recent studies
identify the at-risk population, the common presenting
symptoms and potential pathophysiology underlying vagal
neuropathy, and have proposed several promising medical
interventions [11,28]. The relationship between CC and the
laryngeal area has also been associated with states of hyper-
sensitivity and hyposensitivity of the laryngeal mucosa. First
introduced by Morrison and colleagues [29] in 1999, the
concept of irritable larynx has been refined over the years,
with various terms being used for the same suspected
cause: postviral vagal neuropathy (PVVN), sensory neuro-
pathic cough, and laryngeal sensory neuropathy. The con-
siderable confusion in the terminology has probably added
to the difficulty of treating these pathologies. Vagal neur-
opathy may affect the motor branches of the vagus nerve,
resulting in vocal fold paralysis or paresis, or it may affect
the sensory branches, inducing CC but also a throat tickle,
globus sensation, excessive throat mucus, odynophonia, or
laryngospasm. These symptoms may be aggravated by sen-
sory stimuli such as laughing and prolonged phonation or
noxious stimuli, and can be elicited clinically by palpation
at the cricoid level. Some patients have psychogenic cough
with an identifiable secondary gain or abrupt onset/offset of
the problem.
A problem that may underlie the confusing diagnosis of
refractory CC is the relative neglect of the symptomatic
history prior to onset. Patients usually deny any associated
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aspects should be considered in the early stages. First,
there may be several simultaneous sites of stimulation of
the cough reflex. In one study [8] 62% of patients had two
or more potential sites of origin, and in a study by our
group of 270 patients with CC, 84% presented simultan-
eous sites [30]. Second, laryngeal paresthesias, that is, ab-
normal sensations, may be present in up to 94% of
refractory CC [11]. Paresthesias and triggers of response
to low level stimuli are features of neuropathic sensory de-
fects or vagal neuralgia with central sensitization of the
cough reflex. They have also received limited attention in
the clinical research literature [31], so there is currently a
need for objective measures of triggers and methods to
identify, describe, and quantify laryngeal paresthesias [11].
Laryngeal neuropathy and laryngopharyngeal reflux
A prominent characteristic of neuralgia is the presence of
trigger phenomena. We speculate that a vagal laryngeal
neuralgia may manifest as a sudden, exaggerated, but non-
painful sensation in the vagus nerve that leads to uncon-
trollable coughing. The idea is that the threshold for the
initiation of cough reflex is significantly lowered: thus, a
strong, irresistible signal to cough could result from min-
imal stimuli, or from no stimulus at all. In 2001, Amin
and Koufman [32] first described the association of CC
and previous upper respiratory tract infection. Subsequent
investigation through videostroboscopy and laryngeal elec-
tromyography revealed a variety of presentations: (1) vocal
fold paresis, (2) neuropathy-induced laryngopharyngeal re-
flux disease, (3) dysphagia, and (4) neuropathic pain. In
addition, the association of autosomal dominant heredi-
tary sensory neuropathy with chronic cough and gastro-
esophageal reflux suggests a link between CC and sensory
neuropathy mediated by gastroesophageal reflux [33,34].
The reason why only a few patients with upper re-
spiratory infection develop chronic impairment of the la-
ryngeal afferent branch remains a mystery. Two possible
explanations have been proposed: the patient may de-
velop chronic PVFM (laryngeal neuropathy); alterna-
tively, he/she may simultaneously develop LPR, which
can act in turn as chronic irritant on the larynx. Transi-
ent postviral vocal cord adduction has been demon-
strated by Gibson et al. [35]. These authors argue that
viruses infect the upper airway epithelium causing neural
activation that can lead to either completely reversible
or recurrent cough. PVFM may also be a motor re-
sponse to laryngeal sensory neuropathy. It has been sug-
gested that individuals with PVFM may cough willingly
to cause vocal cord abduction during a PVFM episode
[36]. However, given the frequent association of LPR and
chronic PVFM, the hypothesis is that PVFM persists in
the presence of LPR, with recurrent irritation of the lar-
ynx and pharynx.GER may be clinically silent in as many 75% of patients
referred for CC. Gastric refluxate has been hypothesized
as a likely cause of the impaired laryngopharyngeal sensa-
tion in patients with CC and GERD compared to controls
[3,13]. Decreased mechanosensitivity and chemosensitivity
of the laryngeal mucosa due to chronic acid irritation
could result in increased collection of particulate or irri-
tant matter in the laryngeal area; the chronic cough reflex
may simply be an adaptative mechanism to clear the lar-
ynx [3]. In an elegant paper, Murry et al. quantified the la-
ryngeal sensory response in a cohort of patients with
PVFM and CC who had received twice-daily proton pump
inhibitors for at least three months with no subjective
improvement, and demonstrated that mean bilateral laryn-
geal sensory response improved significantly after com-
bined respiratory retraining and aggressive PPI therapy.
All patients reported improved cough [3].
The most convincing explanation of the relationship be-
tween the states of hypersensitivity and hyposensitivity in
the laryngeal mucosa was recently provided by Cukier-Blaj
et al. [37]. These authors propose that laryngeal irritation
caused by reflux decreases laryngeal sensitivity and results
in a compensatory motor response with a hyperadduction
of the vocal folds during inspiration, cough and dysphonia.
This adaptive mechanism may explain the link between
LPR and laryngeal neuropathy because if sensory deficits
are prolonged in time, aberrant sensory repair regener-
ation or central changes may develop. This proposal may
be supported by the recently reported success of respira-
tory retraining in patients with CC without complete reso-
lution of cough [10,11].
This research in the field of ENT suggests that the
chronic irritation of the larynx due to reflux may cause
two conditions: first, a hyposensitive state with the risk of
developing aspirations and cough; second, a hypersensitive
state in which the larynx is more sensitive to various exter-
nal stimuli [29]. Many patients report developing “sensitiv-
ity” to various non-specific triggers such as cigarette
smoking, cold air, exercise, perfume, clearing agents, odors
and emotional stress. This clinical presentation often leads
to misdiagnosis of asthma or multiple chemical sensitivity.
The disorder may be long-lasting as patients may be un-
successfully treated for asthma and other comorbidities
before correct diagnosis is made. Some patients present
asthma but CC is usually associated with other LPR symp-
toms, episodic choking or shortness of breath, and often
the breathing problems begin at the same time. In these
cases LPR seems to be the cause of, or at least a decisive
factor in, the breathing problems.
The endoscopic examination of the larynx is essential in
all patients with CC since it is important to differentiate
endoscopic signs of LPR from signs of vocal cord paresis
[38]. It has recently been demonstrated that proximal
non-acid reflux disease is more important in CC [39].
Pacheco and Cobeta Cough 2013, 9:10 Page 5 of 7
http://www.coughjournal.com/content/9/1/10Using immunohistochemical analysis, Johnston et al.
showed that 95% of LPR patients had tissue-bound pepsin
within the tissue biopsy specimens, compared with only
5% of controls [40]. The same authors demonstrated that
human pepsin retains some of its proteolytic activity up to
a pH of 6.5 [41]. The speculation that refractory CC may
be due to a form of non-acid reflux that is mainly gaseous,
and is thus undetectable by conventional techniques such
as esophageal pH monitoring or impedance, deserves
more attention. In cases of CC associated with non-acid
reflux, given the ineffectiveness of antacid treatment it
may be advisable to use baclofen, a gamma-aminobutyric
acid (GABA) B agonist which acts by decreasing the num-
ber of lower esophageal sphincter relaxations [42]. More-
over the recent discovery of proton pump activity in
seromucinous glands of the human larynx opens up new
possibilities not only for treatment but for identifying the
pathogenesis of lesions in tissue laryngeal nerve endings,
even without LPR [43].
These findings are clinically relevant in CC of laryngeal
origin. First, the tissue-bound pepsin in these patients
may be activated by any source of exogenous acid, in-
cluding foods and beverages, and the activation of cough
receptors in the larynx may perpetuate in spite of high
doses of PPI and lifestyle modifications. Second, Altman’s
study of the proton pump in the larynx did not contain
enough cases to be able to establish the variability be-
tween individuals; it might be speculated that some pa-
tients with CC and with tissue-bound pepsin in the
larynx could activate pepsin without the need for an ex-
ternal source. What is more, the proteolytic activity of
pepsin in the larynx may result in sensitivity disorders
such as glottic closure reflex and cough reflex.
Chronic cough hypersensitivity syndrome
Chronic cough hypersensitivity syndrome (CCHS) is a
syndrome that identifies a group of patients with unex-
plained chronic cough (UCC) after anatomical diagnosis
of CC. Patients with UCC present abnormal cough reflex.
These patients commonly have a strikingly increased sen-
sitivity to cough challenge with capsaicin, which suggests
an abnormality of the airway sensory nerves. Birring pro-
poses a different term, “cough reflex hypersensitivity”, but
we do not yet have a full exploratory method of the cough
reflex arc covering the two main vagal afferent pathways,
C fibers and cough receptors [44]. The sensory receptors
that mediate cough in humans have not been conclusively
identified, but members of the transient receptor potential
(TRP) ion channel family are strong candidates. There is
evidence of increased expression of TRPV-1 in the airway
nerves of patients with unexplained chronic cough [45],
and a recent study showed that airway inflammation can
initiate the expression of TRPV1 and TRPA1 in airway af-
ferent neurons that normally do not express these ionchannels [46]. Future research should focus on important
mechanisms such as cough reflex hypersensitivity. The
symptoms usually associated with CCHS included persist-
ent tickling or irritating sensation in the chest or throat,
hoarse voice, dysphonia or vocal cord dysfunction (VCD)
[2]. Heightened cough reflex sensitivity can be considered
reversible or persistent in patients with CCHS in whom
the cough is typically dry or minimally productive. Never-
theless, the hypersensitivity of the airway nerves may not
be limited to those involved in cough, and so enhanced
sensitivity of the laryngeal glottic closure reflex and the
high prevalence of VCD and voice disorders in UCC raises
the possibility of a generalized disorder of the airway
nerves [10,47]. Abnormal sensation and triggering of re-
sponses with low-level or non-tussive stimuli are features
of a neuropathic sensory disorder. Tussive triggers are
those known to stimulate cough receptors, such as smoke
and fumes, whereas non-tussive triggers are those not
known to be tussigenic in neurophysiological testing, such
as perfumes, cold air, vocalization, or stress. In addition, if
an abnormal sensation in the laryngeal area occurs in the
absence of exposure to a trigger, then the term used is la-
ryngeal paresthesia (tickle, itching, mucous, tightness etc.).
The triggers are recognized by approximately two thirds
of patients referred with CC [31]; however, laryngeal
paresthesia, as a part of the symptom profile of CC, was
present in 94% of patients with CC which was refractory
to medical management based on the anatomical diagnos-
tic protocol [11].
Morice et al. maintain that the CC is part of a broader
syndrome, termed CCHS. According to these authors, its
pathophysiological basis is acid or non-acid liquid and gas-
eous reflux, and which comprises several phenotypes such
as airway eosinophilic inflammation, GERD or upper airway
involvement. The symptoms reported in the larynx are very
common in this syndrome, and the authors justify their
"unifying" hypothesis because of the greater density of la-
ryngeal cough receptors. However, applying the Hull Cough
Hypersensitivity Questionnaire, they also found evidence of
a common history of all phenotypes of chronic cough [20].
McGarvey challenges this concept on the grounds that
cough reflex hypersensitivity may not be present in all pa-
tients with CC and, in addition, successful treatment is usu-
ally (though not always) associated with reduced cough
sensitivity [48]. However, one of the two types of the affer-
ent nerve conducts of the cough reflex is characterized by
rapidly adapting responses to acidification of the large air-
way epithelium; they are capsaicin-insensitive but may
cause coughing, although no heightened response to tussive
agents such as capsaicin has been detected [15]. In any case,
we believe that if sensory alterations originating in the la-
ryngeal mucosa are included in the diagnosis of CCHS, this
establishes the concept of CC as an altered vagal reflex of
multifactorial origin.
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A long-term follow-up study by pneumologists of patients
with UCC found that cough persisted in most patients but
that its severity was reduced in more than 50% [49]. An-
other study by Vertigan AE et al. showed that CC which
persists despite medical treatment may respond to speech
pathology intervention; improvements were recorded in
88% of participants in the treatment group compared with
14% in the placebo group [10]. The importance of tar-
geting sensation in CC to reduce the laryngeal adduction
reflex in PVFM lies in the fact that it can improve with
pharmacology and behavioral treatment. Voice therapies
that prevent vocal fold hyperadduction are an important
component of behavioral interventions in CC [10]. Re-
spiratory retraining not only alters the respiratory mech-
anism, but also has the capacity to change the inherent
laryngeal sensory response, probably raising the threshold
of the cough reflex.
Most patients with CC have rhinosinusitis, eosinophilic
airway inflammation, allergy or reflux and respond to
some extent to specific therapies for these conditions.
Those who do not respond to empirical therapy should re-
ceive workup for the superior laryngeal nerve or the recur-
rent laryngeal nerve [50]. Lee et al. believe that, as in the
case of neuropathic pain [51], there may be a role for
neuroleptic medication in the treatment of neuromuscular
disorders of the larynx. Open label studies of drugs acting
on peripheral nerves used to treat neuropathic pain, such
as amitriptyline and gabapentin, have been reported to re-
duce cough severity but this issue needs further investiga-
tion in controlled trials [52,53]. At present, the level at
which amitriptyline interferes in the cough reflex is un-
known. Recent pain literature suggests that amitriptyline
has a rapid, long-acting nerve-blocking effect which is su-
perior to that of a classic local anesthetic. We hypothesize
that amitriptyline lowers the sensory threshold of the af-
ferent nerve endings, thus inhibiting the cough reflex.
Since clinical benefit has been described in six patients
with exercise-induced vocal cord dysfunction who inhaled
the anticholinergic drug ipratropium prior to exercise, we
cannot rule out this effect since it is known that amitrip-
tyline is anticholinergic [54].
In conclusion, clinical judgement and symptom ratings
support the hypothesis that the laryngeal area is the “new
frontier” in CC, as the source of a large number of triggers
and paresthesias in patients. Several treatments are avail-
able not only for laryngeal neuropathy but also for chronic
stimuli such as reflux. Speech pathology treatment is an ef-
fective behavioral intervention for chronic cough which
persists despite medical intervention, since it improves sen-
sory function. In addition, bearing in mind the frequently
coincidental onset of neuropathic cough and LPR in pa-
tients with CC, we suggest a double therapy targeting the
larynx and GER. Further research will shed more light onthis issue, especially when the reflux is non-acidic and/or
gaseous. All these treatments required a well-coordinated,
multidisciplinary approach involving pulmonologists, oto-
laryngologists and, gastroenterologists in order to resolve
the problem of refractory CC.
Competing interests
The authors declare that they have no competing interest.
Authors’ contributions
AGP and IC both contributed to writing the manuscript. Both authors read
and approved the final manuscript.
Received: 26 August 2012 Accepted: 11 March 2013
Published: 3 April 2013
References
1. Irwin RS, Bauman MH, Bolser LP, Boulet LP, Braman SS, Brightling CE, et al:
American College of Chest Physicians (ACCP). Diagnosis and
management of cough executive summary: ACCP evidence-based
clinical practice guidelines. Chest 2006, 129(Suppl 1):1S–23S.
2. Chung KF: Chronic “cough hypersensitivity syndrome”: a more precise
label for chronic cough. Pulm Pharmacol Ther 2011, 24:267–271.
3. Murry T, Bransky RC, Yu K, Cukier-Blaj S, Duflo S, Aviv JE: Laryngeal sensory
deficits in patients with chronic cough and paradoxical vocal fold
movement disorder. Laryngoscope 2010, 120:1576–1581.
4. Rees CJ, Henderson AH, Belafsky PC: Postviral vagal neuropathy. Ann Otol
Rhinol Laryngol 2009, 118:247–252.
5. Pacheco A, Faro V, Cobeta I, Molyneux I, Morice AH: Gastro-oesophageal
reflux, eosinophilic airway inflammation and chronic cough. Respirology
2011, 16:994–999.
6. Haque RA, Usmani OS, Barnes PJ: Chronic idiopathic cough: a discrete
clinical entity? Chest 2005, 127:1710–1713.
7. Everett CF, Morice AH: Clinical history in gastroesophageal cough. Respir
Med 2007, 101:345–348.
8. Irwing R: Diagnosis and management of cough: ACCP evidence-based
clinical practice guidelines. Chest 2006, 129:245–254.
9. Morice AH, Fontana GA, Sovijari AR, Pistolesi M, Chung KT, Widdicombe J,
et al: ERS Task Force. The diagnosis and management of chronic cough.
Eur Respir J 2004, 24:481–492.
10. Vertigan AE, Theodoros DG, Gibson PG, Winkworth AL: Efficacy of speech
pathology management for chronic cough: a randomised placebo
controlled trial of treatment efficacy Thorax 2006, 61:1065–1069.
11. Vertigan AE, Gibson PG: Chronic refractory cough as a sensory
neuropathy: evidence from a reinterpretation of cough triggers. J Voice
2011, 25:596–601.
12. Altman KW, Simpson CB, Amin MR, Abaza M, Balkissoon R, Casiano RR:
Cough and paradoxical vocal fold motion. Otolryngol Head Neck Surg
2002, 127:501–511.
13. Phua SY, McGarvey LP, Ngu MC, Ing AJ: Patients with gastroesophageal
reflux disease and cough have impaired laryngopharyngeal
mechanosensitivity. Thorax 2005, 60:488–491.
14. Jordan D: Central nervous mechanism in cough. Pulm Pharmacol 1996,
9:389–392.
15. Canning BJ: Functional implications of the multiple afferent pathways
regulating cough. Pulm Pharmacol Ther 2011, 24:295–299.
16. Undem BJ, Carr MJ: Targeting primary afferent nerves for novel
antitussive therapy. Chest 2010, 137:177–184.
17. Canning BJ: Afferent nerves regulating the cough reflex: mechanisms
and mediators of cough in disease. Otolaryngol Clin N Am 2010, 43:14–25.
18. Canning BJ, Mori N, Mazzone SB: Vagal afferent nerves regulating the
cough reflex. Respir Physiol Neurobiol 2006, 152(3):223–242.
19. Mazzone SB, Mori N, Canning BJ: Synergistic interactions between airway
afferent nerve subtypes regulating the cough reflex in guinea-pigs. J
Physiol 2005, 569:559–573.
20. Morice AH: Review article: reflux and airway disease. Aliment Pharmacol
Ther 2011, 33(1):48–52.
21. Fouad YM, Katz PO, Hatlebakk JG, Castell DO: Ineffective esophageal
motility: the most common motility abnormality in patients with GERD-
associated respiratory symptoms . Am J Gastroenterol 1999, 94:1464–1467.
Pacheco and Cobeta Cough 2013, 9:10 Page 7 of 7
http://www.coughjournal.com/content/9/1/1022. Kawamura O, Aslam M, Rittmann T, Hofmann C, Shaker R: Physical and pH
properties of gastroesophagopharyngeal refluxate: a 24-hour
simultaneous ambulatory impedance and pH monitoring study. Am J
Gastroenterol 2004, 99:1000–1010.
23. Pacheco-Galván A, Hart SP, Morice AH: Relationship between gastro-
oesophageal reflux and airway diseases: The airway reflux paradigm.
Arch Bronconeumol 2011, 47:195–203.
24. Knight RE, Wells JR, Parrish RS: Esophageal dysmotility is an important co-
factor in extraesophageal manifestations of gastroesophageal reflux.
Laryngoscope 2000, 110:1462–1466.
25. Kastelik JA, Redington AE, Aziz I, Buckton GK, Smith CM, Dakkak M, et al:
Abnormal oesophageal motility in patients with chronic cough. Thorax
2003, 58:699–702.
26. Kahrilas PJ, Shaheen NJ, Vaezi MF, Hiltz SW, Black E, Modlin IM, et al:
American gastroenterology association medical position statement on
the management of gastroesophageal reflux disease. Gastroenterolgy
2008, 135:1383–1391.
27. Vertigan AE, Gibson PG, Theodoros DG, Winkworth AL: A review of voice
and upper airway function in chronic cough and paradoxical vocal cord
movement. Curr Opin Allergy Clin Immunol 2007, 7:37–42.
28. Greene SM, Simpson CB: Evidence for sensory neuropathy and
pharmacologic management. Otolaryngol Clin North Am 2010, 42:67–72.
29. Morrison M, Rammage L, Emami AJ: The irritable larynx syndrome. J Voice
1999, 13:447–455.
30. Pacheco A, Wagner C, Nieto R, García L, Jurkojc C, Gotera C, et al: Multiple
dimension of chronic cough. An analysis of 270 cases. Arch Bronconeumol
2012, 48(Espec Cong):1–296.
31. McGarvey L, McKeagney P, Polley L, MacMahon J, Costello RW: Are there
clinical features of a sensitized cough reflex? Pulm Pharmacol Ther
2009, 22:59–64.
32. Amin MR, Koufman JA: Vagal neuropathy after upper respiratory
infections: a viral etiology. Am J Otolryngol 2001, 22:251–256.
33. Kok C, Kennerson ML, Spring PJ, Ing AJ, Pollard JD, Nicholson GA: A locus
for hereditary sensory neuropath with cough and gastroesophageal
reflux on chromosome 3p22-p24. Am J Human Genet 2003, 73:632–637.
34. Spring PJ, Kok C, Nicholson GA, Ing AJ, Spies JM, Bassett ML, et al:
Autosomal dominant hereditary sensory neuropathy with chronic cough
and gastro-esophageal reflux: clinical features in two families linked to
chromosome 3p22-p24. Brain 2005, 128:2797–2810.
35. Taramarcaz P, Grissell TV, Borgas T, Gibson P: Transient postviral vocal cord
dysfunction. J Allergy Clin Immunol 2004, 114:1431–1432.
36. Blager F: Paradoxical vocal fold movement: diagnosis and management.
Curr Opin Otolaryngol Head Neck Sur 2000, 8:180–183.
37. Cukier-Blaj S, Bewley A, Aviv JE, Murry T: Paradoxical vocal fold motion:a
sensory motorlaryngeal disorder. Laryngoscope 2008, 118(2):367–370.
38. Belafsky PC, Postma GN, Koufman JA: The validity and reliability of the
reflux finding score. Laryngoscope 2001, 111:1315–1317.
39. Patterson N, Mainie I, Rafferty G, McGarvey L, Heaney L, Tutuian R, et al:
Nonacid reflux episodes reaching the pharynx are important factors
associated with cough. J Clin Gastroenterol 2009, 43:414–419.
40. Johnston N, Knight J, Dettmar PW, Lively MO, Koufman J: Pepsin and
carbonic anhydrasa isoenzyme III as diagnostic markers for
laryngopharyngeal reflux disease. Laryngoscope 2004, 114:2129–2134.
41. Johnston N, Dettmar PW, Bishwokarma B, Livel MO, Koufman JA: Activity
/stability of human pepsin: implications for reflux attributed laryngeal
disease. Laryngoscope 2007, 117:1036–1039.
42. Zang G, Lehman A, Rigda R, Dent J, Holloway RH: Control of transient
lower oesophageal sphincter relaxations and reflux by the GABA (B) in
patients with baclofen agonist gastro-oesophageal reflux disease. Gut
2002, 50:19–24.
43. Altman KW MD, Haines GK III, Hammer ND 3rd, Radosevich JA: The
H+/K+−ATPase (proton) pump is expressed in human laryngeal
submucosal glands. Laryngoscope 2003, 113:1927–1930.
44. Canning BJ, Chou YL: Cough sensors. Physiological and pharmacological
properties of the afferent nerves regulating cough. Handb Exp Pharmacol
2009, 187:23–47.
45. Groneberg DA, Niimi A, Dinh QT, Cosio B, Hew M, Fischer A, Chung KF:
Increased expression of transient receptor potential vanilloid-1 in airway
nerves of chronic cough. Am J Respir Crit Care Med 2004, 170:1276–1280.
46. Zhang G, Lin RL, Wiggers M, Snow DM, Lee LY: Altered expression of
TRPV1 and sensitivity to capsaicin in pulmonary myelinated afferentsfollowing chronic airway inflammation in the rat. J Physiol 2008, 586
(Pt23):5771–5786.
47. Prudon B, Birring SS, Vara DD, Hall AP, Thompson JP, Pavord ID: Cough and
glottic-stop reflex sensitivity in health and disease. Chest 2005, 127:550–557.
48. Morice AH, McGarvey LP, Dicpinigaitis PV: Cough hypersensitivity syndrome
is an important clinical concept: a pro/con debate. Lung 2012, 190:3–9.
49. Birring SS: Controversies in the evaluation and management of chronic
cough. Am J Respir Crit Care Med 2011, 183:708–715.
50. Lee B, Woo P: Chronic cough as a sign of laryngeal sensory neuropathy:
diagnosis and treatment. Ann Otol Rhinol Laryngol 2005, 114:253–257.
51. Cheshire WP Jr: Defining the role for gabapentine in the treatment of
trigeminal neuralgia: a retrospective study. J Pain 2002, 3:137–142.
52. Jeyakumar A, Brickman TM, Haben M: Effectiveness of amitriptyline versus
cough suppressants in the treatment of chronic cough resulting from
postviral vagal neuropathy. Laryngoscope 2006, 116:2108–2112.
53. Mintz S, Lee JK: Gabapentin in the treatment of intractable idiopathic
chronic cough: case reports. Am J Med 2006, 119:e13–e15.
54. Weinberger M, Abu-Hasan M: Pseudo-asthma: when cough, wheezing and
dyspnea are not asthma. Pediatrics 2007, 120:855–864.
doi:10.1186/1745-9974-9-10
Cite this article as: Pacheco and Cobeta: Refractory chronic cough, or
the need to focus on the relationship between the larynx and the
esophagus. Cough 2013 9:10.Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
